Imaging News

Research in HF, omega-3 fatty acids, cardiac imaging among women and drug-eluting stents are among the topics of late-breaking clinical trials being presented at the virtual American Heart Association Scientific Sessions.

There may be a link between COVID-19 and HF with preserved ejection fraction, as infection from SARS-CoV-2 may cause, unmask or exacerbate HFpEF, according to a viewpoint published in JAMA.

Healio and Cardiology Today have curated a list of the most-read cardiology news of September.

Utilization of pyrophosphate imaging to identify patients with cardiac amyloidosis has increased, although questions remain regarding its use for screening and to assess responses to therapy, according to a presentation.

Among patients with diabetes, risk for MI was elevated in those with CAD, but not in those without it, according to a poster presented at the European Society of Cardiology Congress.

PET perfusion and flow assessment may guide revascularization strategies for patients with CAD, according to a presentation at the Scientific Session and Exhibition of the American Society of Nuclear Cardiology.

As clinicians around the world rapidly transitioned from in-person to telehealth visits during the COVID-19 pandemic, it required managing many changes at once.

Acutus Medical announced that a second-generation 3D imaging and mapping catheter for atrial arrhythmias received 510(k) clearance from the FDA.

Coronary artery plaque lipid-rich necrotic core was associated with psoriasis severity and may be improved with biologic therapy, researchers reported.

Cardiac MRI may help assess risk for myocarditis in athletes recovering from COVID-19 to determine whether it is safe to participate in competitive sports, researchers found.